Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review.
about
Glypican-3 Targeting Immunotoxins for the Treatment of Liver CancerPharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis.Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review.
P2860
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Outcome and Safety of Sorafeni ...... Patients: A Systematic Review.
@en
type
label
Outcome and Safety of Sorafeni ...... Patients: A Systematic Review.
@en
prefLabel
Outcome and Safety of Sorafeni ...... Patients: A Systematic Review.
@en
P50
P1476
Outcome and Safety of Sorafeni ...... Patients: A Systematic Review.
@en
P2093
Bruno Castagneto
Giovanni Di Meglio
P304
P356
10.1016/J.CLGC.2016.01.010
P407
P577
2016-01-28T00:00:00Z